Zantac State Court Battles Heat Up: Plaintiffs Call for Judge Recusal Amidst Conflict of Interest Concerns
Philadelphia — The future of numerous Zantac cancer lawsuits appears uncertain after a pivotal legal blow in which a federal judge dismissed all cases consolidated under the multidistrict litigation (MDL) system, a decision that could potentially sideline thousands of claims unless overturned on appeal. The shockwaves of this decision extend across various state courts, with new filings and ongoing pretrial activities highlighting the resistant pulse of litigation against Zantac’s manufacturers. Zantac, a popular heartburn medication, was pulled from the market in 2020 after it was discovered that the drug could degrade into N-nitrosodimethylamine (NDMA), a … Read more